124 related articles for article (PubMed ID: 1803712)
1. Breast cancer estrogen and progesterone receptors: associations with patients' clinical and epidemiologic characteristics. G.I.V.I.O. (Interdisciplinary Group for Cancer Care Evaluation), Italy.
Tumori; 1991 Dec; 77(6):472-8. PubMed ID: 1803712
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome. Institut Curie Breast Cancer Study Group.
Bernoux A; de Cremoux P; Lainé-Bidron C; Martin EC; Asselain B; Magdelénat H
Breast Cancer Res Treat; 1998 Jun; 49(3):219-25. PubMed ID: 9776505
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors as prognostic factors in breast cancer.
Brdar B; Graf D; Padovan R; Nola P; Rudan N; Petrinec Z; Sarcević B; Belicza M
Tumori; 1988 Feb; 74(1):45-52. PubMed ID: 3354064
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?
Wang N; Wang B; Wang Y; Hu J
Breast; 2011 Dec; 20(6):519-24. PubMed ID: 21700456
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance.
Thorpe SM
Acta Oncol; 1988; 27(1):1-19. PubMed ID: 3284552
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptor profile patterns in primary breast cancer.
Thorpe SM; Rose C; Pedersen BV; Rasmussen BB
Breast Cancer Res Treat; 1983; 3(1):103-10. PubMed ID: 6871479
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
10. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptors and prognosis in operable (stage I and II) breast cancer.
Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442
[TBL] [Abstract][Full Text] [Related]
13. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
Redkar AA; Kabre SS; Mittra I
Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
[TBL] [Abstract][Full Text] [Related]
14. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
16. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
Iino Y
Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.
Ruder AM; Lubin F; Wax Y; Geier A; Alfundary E; Chetrit A
Cancer; 1989 Jul; 64(1):196-202. PubMed ID: 2731116
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings.
Stierer M; Rosen H; Weber R; Hanak H; Auerbach L; Spona J; Tüchler H
Breast Cancer Res Treat; 1998 Jul; 50(2):125-34. PubMed ID: 9822217
[TBL] [Abstract][Full Text] [Related]
19. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
